Amsterdam, Netherlands

Christopher David Bayer

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christopher David Bayer: Innovator in Trehalose Production

Introduction

Christopher David Bayer is an accomplished inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the production of trehalose, a sugar with various applications in food and pharmaceuticals. With a total of two patents to his name, Bayer's work showcases his innovative approach to solving complex problems in sugar production.

Latest Patents

Bayer's latest patents focus on a method for producing trehalose employing a trehalose phosphorylase variant. This invention involves a detailed process that includes mixing and reacting various components. The method utilizes at least one alpha-phosphorylase to catalyze the production of an alpha-D-glucose 1-phosphate intermediate from a saccharide raw material and a phosphorus source. Additionally, it incorporates a trehalose phosphorylase variant that differs from the wild type in at least one amino acid position. This innovative approach aims to enhance the efficiency of trehalose production.

Career Highlights

Throughout his career, Christopher David Bayer has worked with notable companies such as C-lecta GmbH and New Matterhorn, LLC. His experience in these organizations has allowed him to refine his skills and contribute to advancements in biochemistry and sugar production.

Collaborations

Bayer has collaborated with esteemed colleagues, including Andreas Vogel and Marc Struhalla. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Christopher David Bayer is a prominent figure in the field of trehalose production, with a focus on innovative methods that enhance efficiency. His contributions through patents and collaborations highlight his commitment to advancing biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…